Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2018 12:08 ET | Source: Y-mAbs

Y-mAbs Receives Breakthrough Therapy Designation for Naxitamab for the Treatment of High Risk Neuroblastoma

NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (YmAbs), an immunotherapy company discovering and developing innovative treatments for patients with cancer, today announced...